Company Overview and News

12
Top 50 Real Estate WallStars Show Yields To 15.26% And Net Gains To 131.29% By September 2019

2018-09-21 seekingalpha
WallStars show positive broker target price upsides. IRSA Propiedades flaunted top net gains, while Government Properties showed the highest yield.
GEO ORC ASHFP CHMI CYORP CIM AHT.WI TWO AGNC CIO AJXA GOV NRZ MFO GLPI GOVNI MFA SIR AJX AHT

17
4 Bottom-Ranked mREIT Stocks to Stay Away From

2018-08-31 zacks
Near-term growth prospects of mortgage real estate investment trusts (mREITs) are being questioned, as interest-rate hikes and periodic bouts of volatility in the broader financial markets continue to affect financials of these companies.
NYMTO NYMTP FMCKI FMCKJ SCVL EARN AJXA FMCCO FMCCP FMCCM FMCCN MFO FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK FMCKL PAYC MFA FMCC NYMT AJX FMCCS FMCCT

13
50 Russell Index Stocks Yield 5.7% To 12% For August

2018-08-28 seekingalpha
"All Russell US Indexes are subsets of the Russell 3000 Index, [namely] large-cap Russell 1000 & small-cap Russell 2000 Indexes. These Indexes are. building blocks of financial-products [and] performance-benchmarks."---ftserussell.com.
GEO LB ORC STWD.WI ASHFP AHT.WI TWO TUP OUT AJXA KDP NRZ DX SFL VGR SIR GNL JCAP STWD AJX AHT

 
Great Ajax Corp (AJX) CEO Lawrence Mendelsohn on Q2 2018 Results - Earnings Call Transcript

2018-08-11 seekingalpha
Good afternoon, everyone, and welcome to the Great Ajax Corporation Second Quarter 2018 Financial Results Conference Call. [Operator Instructions]. Please also note, today's event is being recorded. At this time, I'd like to turn the conference call over to Mr. Lawrence Mendelsohn, CEO. Sir, please go ahead.
AJX AJXA

20
Top 50 High Yield Real Estate WallStars Show Gains To 89.2% For August 2019

2018-08-08 seekingalpha - 2
WallStars show positive broker target price upsides. IRSA Propiedades flaunted top net gains, while Orchid Island Capital showed the highest yield.
GEO LMRK ANH ORC ASHFP CHMI CIM TWO AJXA IRCP NRZ SIR JCAP AHT GMRE AHT.WI MFO DX LMRKO MFA LMRKP GNL CLNY IRS AJX

17
5 Russell 3000 Top Dogs Fetch >24% Net Gains Per Brokers To July 2019

2018-07-18 seekingalpha
"All Russell US Indexes are subsets of the Russell 3000 Index, [namely] large-cap Russell 1000 & small-cap Russell 2000 Indexes. These Indexes are. building blocks of financial-products [and] performance-benchmarks." - FTSE Russell.
SNH ANH ORC CHMI CIO AJXA NRZ JCAP SLD SLDA WSR LB STWD.WI CYORP GMRE SNHNL SNHNI PEGI DX SFL ARR GNL IVR CLNY PEG STWD AJX

41
Top 50 High Yield Real Estate Issues Show Gains To 42.6% By June 2019

2018-06-29 seekingalpha
Landmark Infrastructure flaunted top net gains, while Orchid Island Capital had highest yield. Top ten gainers, IVR, TWO,WSR, ORC, EARN, NRZ, DX, CHMI, AJX, & LMRK ranged 10.6%-42.6% 6/28/18.
NYMTO ORC CHMI NYMTP EARN TWO AGNC AJXA NRZ DX NLY CYS IVR NYMT AJX

36
5 Russell 3000 Top Dogs Exceed 15% Target Net Gains To June 2019

2018-06-11 seekingalpha - 1
"All Russell US Indexes are subsets of the Russell 3000 Index, [namely] large-cap Russell 1000 & small-cap Russell 2000 Indexes. These Indexes are. building blocks of financial-products [and] performance-benchmarks."---ftserussell.com.
ANH NYMTO ORC STWD.WI CHMI NYMTP GMRE TWO AJXA PEGI NRZ DX NLY CYS PEG NYMT STWD AJX

65
Top 51 Real Estate WallStars Flaunt Yields To 12.2% And Target Gains To 111.3% By May 2019

2018-05-29 seekingalpha - 1
IRSA Propiedades led by net gains, while Two Harbors led by yield. Top ten gainers, GLPI, AJX, BPY, RESI, HASI, APTS, LMRK, CLNS, IRS, & IRCP gains ranged 17.8%-111.3% 5/25/18.
SLDA LMRK ANH ABRN CIM TWO AJXA ABR CLNS NRZ DX GLPI ARR ABRN.CL IVR AJX

46
50 Russell 3000 Stocks Yield 7.34% To 14.96% For May

2018-05-08 seekingalpha
"All Russell US Indexes are subsets of the Russell 3000 Index, [namely] large-cap Russell 1000 & small-cap Russell 2000 Indexes. These Indexes are. building blocks of financial-products [and] performance-benchmarks."---ftserussell.com.
SLDA NYMTO ORC STWD.WI CHMI NYMTP GMRE TWO AGNC AJXA PEGI NRZ NLY CYS SIR GNL PEG NYMT STWD AJX

6
Great Ajax's (AJX) CEO Larry Mendelsohn on Q1 2018 Results - Earnings Call Transcript

2018-05-02 seekingalpha
Good afternoon and welcome to the Great Ajax Corporation's First Quarter 2018 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions]. Please note, this event is being recorded.
AJX FNMA AJXA

4
Great Ajax Corp 2018 Q1 - Results - Earnings Call Slides

2018-05-01 seekingalpha
The following slide deck was published by Great Ajax Corp in conjunction with their 2018 Q1 earnings call.
AJX AJXA

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

CUSIP: 38983D409